Clinical Trial Update: Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients

View source ↗

Summary

This clinical trial update reports on the tolerability of the Exelon Patch (rivastigmine) for patients with Alzheimer's disease and notes completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Exelon Patch (rivastigmine transdermal patch)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Alzheimer's Disease | Status: COMPLETED